Business Context and Reporting Period
This Form 8-K filing by Cortexyme, Inc. (CRTX) reports a material definitive agreement entered into on February 5, 2020. The company is an emerging growth company incorporated in Delaware with principal executive offices in South San Francisco, California.
Key Financial Metrics
The filing details a private placement offering with the following specific metrics:
- Gross Proceeds: $125.0 million
- Shares Issued: 2,500,000 shares of common stock
- Purchase Price: $50.00 per share
- Expected Closing Date: February 10, 2020
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity positions as this is a transactional report rather than a periodic financial statement.
Material Changes
The primary material change is the entry into Stock Purchase Agreements with certain accredited investors, including an entity affiliated with David A. Lamond, a member of the board of directors. This transaction represents a significant capital raise intended to fund company operations.
Guidance, Outlook, and Risks
Management Commentary and Obligations: The Company agreed to file a registration statement with the SEC within 60 days after the closing of the Offering to register the resale of the Shares. The Company will bear all fees and expenses related to this registration.
Regulatory Context: The shares were offered and sold pursuant to an exemption from registration requirements under Section 4(a)(2) of the Securities Act of 1933, as a transaction with accredited investors not involving a public offering.
Risks and Contingencies: The filing does not explicitly list new risks or contingencies beyond the standard regulatory requirements for the resale registration.
Investor Verification Checklist
- Confirm the closing of the $125.0 million offering on or around February 10, 2020.
- Verify the filing of the registration statement for the resale of shares within the 60-day post-closing window.
- Review the full text of the Stock Purchase Agreement (Exhibit 4.1) for specific covenants or restrictions.
- Monitor the press release (Exhibit 99.1) for additional strategic context regarding the use of proceeds.